STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GPCR STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

交易中 12-23 12:34:54 EST

28.19

+0.29

+1.04%

最高29.06	最低27.78	成交量35.11万
今开28.53	昨收27.90	日振幅4.59%
总市值16.14亿	流通市值15.28亿	总股本5,726万
成交额993.00万	换手率0.65%	流通股本5,421万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GPCR","market":"US","secType":"STK","nameCN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","latestPrice":28.19,"timestamp":1734975292160,"preClose":27.9,"halted":0,"volume":351098,"delay":0,"floatShares":54207693,"shares":57260672,"eps":-2.215678,"marketStatus":"交易中","marketStatusCode":2,"change":0.29,"latestTime":"12-23 12:34:54 EST","open":28.53,"high":29.06,"low":27.7801,"amount":9930023.98146,"amplitude":0.045875,"askPrice":28.22,"askSize":20,"bidPrice":28.15,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-2.215678,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"listingDate":1675400400000,"adjPreClose":27.9,"adrRate":3,"preHourTrading":{"tag":"盘前","latestPrice":28.6,"preClose":27.9,"latestTime":"09:10 EST","volume":1113,"amount":32090.787309,"timestamp":1734963046897},"postHourTrading":{"tag":"盘后","latestPrice":27.89,"preClose":27.9,"latestTime":"19:51 EST","volume":58011,"amount":1618340.4479,"timestamp":1734742271199},"volumeRatio":0.474672,"impliedVol":0.9134,"impliedVolPercentile":0.8247},"requestUrl":"/m/hq/s/GPCR","defaultTab":"news","newsList":[{"id":"2493564478","title":"硕迪生物盘中异动 急速下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493564478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493564478?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:53","pubTimestamp":1734720785,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日02时53分，硕迪生物股票出现异动，股价急速跳水5.26%。机构评级方面，在所有11家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.52%。硕迪生物公司简介：硕迪生物技术有限公司是一家临床阶段的生物制药公司，旨在开发和提供新型口服治疗药物，以治疗多种未满足医疗需求的慢性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221025306ab87ce50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221025306ab87ce50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"2493270934","title":"BUZZ--美国股票走势-Spire、铜矿商、Abercrombie & Fitch","url":"https://stock-news.laohu8.com/highlight/detail?id=2493270934","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493270934?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:41","pubTimestamp":1734720117,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      新闻早报通讯：      12月20日 - 华尔街主要股指周五在震荡交投中跳涨，原因是一份冷于预期的通胀报告缓解了美联储预测2025年仅两次降息引发的一些市场担忧。美国东部时间13:30，道琼斯工业平均指数  上涨1.47%，报42963.15点；标普500指数  上涨1.36%，报5947.02点；纳斯达克综合指数  上涨1.34%，报19632.11点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEM","SIRI","SQQQ","ISSC","FDX","DOG","SCCO","HUMA","SDOW","TQQQ","SNPS",".IXIC",".DJI","SOL","DXD",".SPX","X","MRK","USJW.SI","LU0719512351.SGD","AVO","QID","AADI","NVIW.SI","DJX","ALT","APLM","DDM","NQmain","MNQmain","KMX","CCL","GPCR","USAW.SI","WGO","LU1037948897.HKD","PSQ","FCX","LU1934455194.USD","GALT","VKTX","QLD","TSYW.SI","SR","IONS","AMGN"],"gpt_icon":1},{"id":"2492440770","title":"BUZZ--美国股票走势-Mission Produce、Sirius XM、嘉年华公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492440770","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492440770?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:39","pubTimestamp":1734709181,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      12月20日 - 标普500指数和纳斯达克指数周五下跌，原因是市场担心明年的高利率问题，尽管一份冷于预期的通胀报告抑制了损失。美国东部时间10:30，道琼斯工业平均指数  上涨0.61%，报42601.62点。标普500指数  上涨0.49%，报5895.94点；纳斯达克综合指数  上涨0.44%，报19457.30点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XM",".DJI","QLD","USJW.SI","DNMR",".IXIC","AVO","FDX","X","NVIW.SI","VNCE","SOL","SQQQ","FDS","QID","MNQmain","HUMA","SIRI","AMGN","PSQ","TQQQ","NQmain","DDM","DJX","GALT","KMX","TSYW.SI","KUKE",".SPX","MRK","SDOW","ALT","DXD","NVO","CLW","APLM","WGO","IONS","DOG","AADI","SNPS","VKTX","LLY","USAW.SI","CCL","IIPR","GPCR"],"gpt_icon":1},{"id":"2492544239","title":"背景资料-减肥药开发商排队开发价值 1500 亿美元的市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2492544239","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492544239?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:59","pubTimestamp":1734706761,"startTime":"0","endTime":"0","summary":"与Wegovy试验68周后体重减轻约15%相比， 。11 月，该公司称，在一项早期试验中，该药物帮助 9 名接受最高 100 毫克剂量治疗的患者在 28 天后平均减轻了 8.2% 的体重。该公司在 8 月份表示，它将在今年下半年开始与其他制药公司洽谈开发和商业化 petrelintide 的潜在合作事宜。Zealand 公司目前正在进行一项中期研究，在没有 2 型糖尿病的超重或肥胖患者中测试 petrelintide。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","MRK","IE00B2B36J28.USD","LU0471298777.SGD","SG9999018865.SGD","LU2211815571.USD","LU0965509010.AUD","LU2237443382.USD","LU2361045086.USD","IE00B1BXHZ80.USD","NVO","LU2461242641.AUD","LU2242652126.USD","LU1989772923.USD","LU1941712348.USD","GPCR","LU1868837300.USD","LLY","IE00BJT1NW94.SGD","AMGN","LU0079474960.USD","SG9999015945.SGD","LU2089984988.USD","LU1868836757.USD","PFE","SG9999018857.SGD","LU1093756325.SGD","IE00BJLML261.HKD","ALT","IE000M9KFDE8.USD","LU0708995401.HKD","LU0122379950.USD","LU2491050071.SGD","LU2602419157.SGD","OPK","LU1037948897.HKD","LU0097036916.USD","LU2361044865.SGD","LU1917777945.USD","LU0466842654.USD","SG9999002224.SGD","LU0203202063.USD","IE0002141913.USD","SGXZ99366536.SGD","LU0203201768.USD","LU0861579265.USD","BK4534","SGXZ57979304.SGD","IE00BK4W5M84.HKD","LU0354030511.USD"],"gpt_icon":1},{"id":"2492449584","title":"BUZZ--美国股票走势-Humacyte、Ionis 制药公司、Emeren 集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2492449584","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492449584?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:12","pubTimestamp":1734703974,"startTime":"0","endTime":"0","summary":"** 联邦快递FDX.N:BUZZ - 分析师认为联邦快递分拆货运部门是有益的；将PT升至 nL4N3NL0I5 。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nL4T3NL0VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJLML261.HKD","LU0820561818.USD","LU0109392836.USD","LU0096364046.USD","LU2458330169.SGD","SGXZ81514606.USD","LU0114720955.EUR","SG9999015986.USD","SOL","BK4555","LLY","LU0157215616.USD","LU1914381329.SGD","LU0256863902.USD","AADI","ANSS","IONS","LU0466842654.USD","SG9999015978.USD","X","WGO","BK4133","SNPS","LU2458330243.SGD","HUMA","LU0823416689.USD","LU1429558221.USD","LU2361044949.HKD","ALT","GALT","FDX","LU0061475181.USD","APLM","LU0310800965.SGD","KMX","LU2238339852.HKD","AMPS","LU0957791311.USD","LU2357305700.SGD","LU1988902786.USD","AMGN","LU1280957306.USD","LU1878469433.USD","LU0094547139.USD","LU0348723411.USD","VKTX","GPCR","TSYW.SI","IE00B4R5TH58.HKD"],"gpt_icon":1},{"id":"2492414611","title":"BUZZ--美国股票走势-联邦快递、礼来公司、Aadi 生物科学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492414611","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492414611?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:04","pubTimestamp":1734696255,"startTime":"0","endTime":"0","summary":"** 联邦快递  ： BUZZ - 分析师认为联邦快递分拆货运卡车部门是有益的；上调PT   ** Eli Lilly and Co   : BUZZ - 诺和诺德的下一代肥胖症药物在研究中表现不佳，导致价格上涨   ** Humacyte   : BUZZ - 因血管植入物获得 FDA 批准而上涨逾 40   ** 美国钢铁  : BUZZ - 在预测第四季度意外亏损后下跌   ** Aadi Bioscience   : BUZZ - 因癌症药物许可协议而上涨   ** Viking Therapeutics   ：** Structure Therapeutics   ：** Altimmune   ：** 安进  ： BUZZ - 诺和诺德的肥胖症药物在研究中表现不佳，减肥药开发商获得收益   ** Ionis Pharmaceuticals   : BUZZ - 因FDA批准遗传性疾病药物而上涨","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4585","IE00B1BXHZ80.USD","LU0114720955.EUR","LU2265009873.SGD","LU0882574139.USD","HUMA","X","LU0079474960.USD","LU1551013425.SGD","LU1061106388.HKD","AMGN","LU1878469433.USD","LU0289739699.SGD","BK4588","BK4006","LU1814569148.SGD","LU0471298694.HKD","LU0820561909.HKD","IE00BJT1NW94.SGD","GPCR","LU1035775433.USD","LU0310800965.SGD","LU1064131342.USD","LU2602419157.SGD","LU1093756325.SGD","IE00B4R5TH58.HKD","LU0742534661.SGD","IONS","AADI","LU1868836591.USD","LU2089984988.USD","LU0058720904.USD","FDX","LU2360106947.USD","SG9999001440.SGD","VKTX","LU0354030438.USD","LU0466842654.USD","LU1988902786.USD","LU0354030511.USD","SG9999018857.SGD","SG9999017495.SGD","LLY","ALT","BK4520","LU0238689110.USD","LU0122379950.USD","LU0320765992.SGD","LU1868837300.USD"],"gpt_icon":1},{"id":"2492241903","title":"BUZZ-诺和诺德肥胖症药物在研究中表现不佳，减肥药开发商获益匪浅","url":"https://stock-news.laohu8.com/highlight/detail?id=2492241903","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492241903?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:40","pubTimestamp":1734694859,"startTime":"0","endTime":"0","summary":"    12月20日 - ** 诺和诺德公司的  下一代肥胖症实验药物在后期试验中的减重效果低于预期，一些减肥药开发商的股票在盘前上涨** 诺和诺德称其药物CagriSema帮助超重患者减轻了22.7%的体重 ，低于其25%的预期。** 诺和诺德在美国上市的股票下跌 22.4%，而竞争对手礼来  上涨 10** 投资者和分析师热切期待着这一数据，以检验诺和诺德是否拥有强大的药物管线，在竞争激烈的抗肥胖症市场上紧随Wegovy之后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU1868836757.USD","LU0640476718.USD","LU0820561818.USD","LU1712237335.SGD","IE00BK4W5M84.HKD","LU1804176565.USD","LU2237443978.SGD","LU0198837287.USD","LU0882574139.USD","LU1291159041.SGD","LU1623119135.USD","AMGN","LU1878469433.USD","LU0203202063.USD","LU0385154629.USD","LU1551013342.USD","IE00BJJMRZ35.SGD","LU1814569148.SGD","LU0320765059.SGD","LU0820561909.HKD","IE00BJT1NW94.SGD","GPCR","SG9999001176.SGD","SGXZ57979304.SGD","LU2461242641.AUD","LU2242652126.USD","LU0943347566.SGD","LU1983299246.USD","NVO","LU0109391861.USD","LU2361044865.SGD","LU2089984988.USD","LU1571399168.USD","VKTX","LU0354030438.USD","LU2491050154.USD","IE00BZ1G4Q59.USD","LU0256863811.USD","LU2237438978.USD","LLY","ALT","LU1868836914.USD","LU2264538146.SGD","SG9999014906.USD","SG9999014898.SGD","IE00BKVL7J92.USD","LU0689472784.USD","LU0471298777.SGD","LU0096364046.USD"],"gpt_icon":1},{"id":"2492910119","title":"HC Wainwright & Co.：重申Structure Therapeutics评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2492910119","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492910119?lang=zh_cn&edition=full","pubTime":"2024-12-20 01:18","pubTimestamp":1734628696,"startTime":"0","endTime":"0","summary":"HC Wainwright&Co.：重申Structure Therapeutics评级，由买入调整至买入评级,目标价由80.00美元调整至80.00美元。公司主要候选产品是GSBR-1290，一种口服和偏倚的胰高血糖素样肽-1受体小分子激动剂，这是一种有效的g蛋白偶联受体药物靶点，用于治疗2型糖尿病和肥胖症。该公司还在开发针对其他GPCRs的口服小分子治疗药物，用于治疗肺部和心血管疾病，包括ANPA-0073和LTSE-2578。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220012509ab84e51d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220012509ab84e51d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","LENZ"],"gpt_icon":0},{"id":"2492675171","title":"硕迪生物盘中异动 股价大涨5.16%报29.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492675171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492675171?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:46","pubTimestamp":1734619573,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时46分，硕迪生物股票出现异动，股价快速上涨5.16%。截至发稿，该股报29.34美元/股，成交量7.0458万股，换手率0.12%，振幅6.20%。机构评级方面，在所有11家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为3.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219224613a1fb5cd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219224613a1fb5cd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"2492518003","title":"BUZZ--美国股票走势-美国电池技术公司、奥利廉价直销店、BioAge 实验室","url":"https://stock-news.laohu8.com/highlight/detail?id=2492518003","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492518003?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:49","pubTimestamp":1734536958,"startTime":"0","endTime":"0","summary":"标普500指数  上涨0.17%，报6,060.78点；纳斯达克综合指数  上涨0.15%，报20,139.86点。** Cognition Therapeutics   : BUZZ - 因痴呆症药物在中期试验中达到主要目标而上涨   ** 通用磨坊  : BUZZ - 因下调年度利润预期而下跌   ** Oklo   : BUZZ - 因与人工智能公司斯维奇达成部署12吉瓦核电的协议而上涨   ** 捷普  : BUZZ - 因第一季度业绩超预期而上涨   ** Inotiv   : BUZZ - 因股票发行定价而下跌   ** Xometry   : BUZZ - 摩根大通将 Xometry 的评级提升至 \"增持\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX","ESmain","NOTV","DDM","SDOW","COMM","DXD","OLLI","IVV","NVDU","SPXU",".IXIC","XMTR","SNVD.UK","MTCH","UPRO","MYPS","GIS","GETY","NVDS","AAPL","GPCR","SSO","NVDA","ACHR","YY","NVD2.UK","NVDS.UK","DJX","OEX",".DJI","NVD","JBL",".SPX","PKG","SDS","SH","3NVD.UK","BIRK","SPY","ABAT","NVIW.SI","MU","ANGI","DOG","BIOA","2NVD.UK","VKTX","NVDX"],"gpt_icon":1},{"id":"2492787189","title":"BUZZ-默克公司签署 20 亿美元开发肥胖症口服药协议后，部分肥胖症药物开发商股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2492787189","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492787189?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:28","pubTimestamp":1734532124,"startTime":"0","endTime":"0","summary":"12月18日 -  ** 肥胖症药物开发商Structure Therapeutics GPCR.O和Viking Therapeutics VKTX.O的股价在盘前交易中下跌7%至8  ** GPCR 下跌 7.2%，报 29.20 美元；VKTX 下跌 8.3%，报 42.80 美元 ** 默克MRK.N与汉寿制药3692.HK在 ，以开发和销售这家中国生物技术公司的实验性口服肥胖症药物。** 截至上次收盘，GPCR 下跌 22.8%，而 VKTX 则累计上涨 150.9 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nL4T3NJ11L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689472784.USD","LU1551013342.USD","IE00BJLML261.HKD","LU0203201768.USD","LU0354030438.USD","LU0672654240.SGD","SG9999002232.USD","BK4139","LU0354030511.USD","LU0203202063.USD","PFE","LU1623119135.USD","LU1571399168.USD","LU1868837300.USD","LU0320765489.SGD","LLY","SG9999018857.SGD","BK4007","LU0965508806.USD","LU0225771236.USD","LU0265550359.USD","LU0238689110.USD","01638","03692","LU1037948897.HKD","LU1066051225.USD","SG9999001176.USD","SGXZ57979304.SGD","LU1057294990.SGD","LU1069344957.HKD","SG9999003800.SGD","LU2237443382.USD","LU2265009873.SGD","BK1191","LU1989772840.SGD","LU0321505439.SGD","SG9999014567.USD","LU1585245621.USD","GPCR","IE00BLSP4239.USD","LU0861579265.USD","LU0114720955.EUR","VKTX","LU0198837287.USD","LU2361044865.SGD","MRK","LU1127390331.HKD","IE00B2B36J28.USD","LU0306807586.USD","IE00BJT1NW94.SGD"],"gpt_icon":1},{"id":"2491355456","title":"硕迪生物盘中异动 快速下跌5.08%报32.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491355456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491355456?lang=zh_cn&edition=full","pubTime":"2024-12-13 02:43","pubTimestamp":1734029031,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日02时43分，硕迪生物股票出现波动，股价急速下挫5.08%。截至发稿，该股报32.51美元/股，成交量27.2281万股，换手率0.48%，振幅6.89%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-34.26百万美元，每股收益-0.60美元，毛利-267175.50美元，市盈率-15.11倍。机构评级方面，在所有11家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为1.02%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213024352a1e9c017&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213024352a1e9c017&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4599","GPCR"],"gpt_icon":0},{"id":"1173408942","title":"异动解读 | STRUCTURE THERAPEUTICS INC盘中大涨7.98%,多家券商给予买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1173408942","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173408942?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:38","pubTimestamp":1733755127,"startTime":"0","endTime":"0","summary":"STRUCTURE THERAPEUTICS INC 今日盘中大涨7.98%,股价涨幅引发了市场关注。从公司基本面看,STRUCTURE THERAPEUTICS INC是一家临床阶段的生物制药公司,主要开发治疗糖尿病、肥胖症等慢性病的候选药物。另外,据最新财报数据显示,该公司虽然目前处于研发投入期暂无营收,但机构对其发展前景仍然持看好态度。目前有100%的参与评级机构给予该股买入评级,并无任何卖出或持有评级。这可能是推动其股价上涨的重要原因之一。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | STRUCTURE THERAPEUTICS INC盘中大涨7.98%,多家券商给予买入评级","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GPCR"],"gpt_icon":0},{"id":"2490738487","title":"硕迪生物盘中异动 大幅上涨6.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490738487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490738487?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:31","pubTimestamp":1733754704,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时31分，硕迪生物股票出现波动，股价急速上涨6.84%。截至发稿，该股报35.63美元/股，成交量4.6553万股，换手率0.08%，振幅1.63%。机构评级方面，在所有11家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223144984ac468&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223144984ac468&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"1113073375","title":"异动解读 | 硕迪生物盘中股价大跌5.68%,原因或与财报数据和行业表现有关","url":"https://stock-news.laohu8.com/highlight/detail?id=1113073375","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113073375?lang=zh_cn&edition=full","pubTime":"2024-12-06 01:46","pubTimestamp":1733420779,"startTime":"0","endTime":"0","summary":"硕迪生物(GPCR)今日盘中大跌5.68%,引起了市场的广泛关注。\n\n消息面上,该公司最新财报数据显示营收为0,净亏损3426万美元,每股亏损0.6美元。财报数据并不理想,可能是导致股价下跌的一个重要原因。\n\n另外,硕迪生物所属的生物技术行业今日整体涨幅仅为0.27%,表现一般。同行业内其他个股如Molecular Templates等股价振幅较大,或许也对硕迪生物股价产生了一定影响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 硕迪生物盘中股价大跌5.68%,原因或与财报数据和行业表现有关","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GPCR"],"gpt_icon":0},{"id":"2489498735","title":"硕迪生物盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489498735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489498735?lang=zh_cn&edition=full","pubTime":"2024-12-06 01:28","pubTimestamp":1733419701,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日01时28分，硕迪生物股票出现异动，股价急速下跌5.13%。截至发稿，该股报31.83美元/股，成交量21.1646万股，换手率0.37%，振幅6.40%。机构评级方面，在所有11家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.27%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206012822a1d6ed6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206012822a1d6ed6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"2488113235","title":"硕迪生物盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488113235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488113235?lang=zh_cn&edition=full","pubTime":"2024-12-04 23:44","pubTimestamp":1733327087,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时44分，硕迪生物股票出现异动，股价急速拉升5.02%。截至发稿，该股报34.92美元/股，成交量9.3827万股，换手率0.16%，振幅6.32%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为0.04%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204234447971ba471&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204234447971ba471&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"2488670238","title":"硕迪生物盘中异动 股价大涨5.13%报34.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488670238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488670238?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:25","pubTimestamp":1733153108,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时25分，硕迪生物股票出现异动，股价大幅拉升5.13%。截至发稿，该股报34.85美元/股，成交量13.1083万股，换手率0.23%，振幅5.40%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-34.26百万美元，每股收益-0.60美元，毛利-267175.50美元，市盈率-16.09倍。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202232509abf01d68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202232509abf01d68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR","BK4599"],"gpt_icon":0},{"id":"2486705257","title":"单月超6亿美元，医药企业IPO规模重返疫情前水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2486705257","media":"财通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486705257?lang=zh_cn&edition=full","pubTime":"2024-11-25 17:34","pubTimestamp":1732527240,"startTime":"0","endTime":"0","summary":"今年以来，生物医药领域已经有30家公司IPO上市，累计融资规模超40.49亿美元，其中不乏CG Oncology、Kyverna Therapeutics等IPO规模超3亿美元的公司。在多肽类PTH1R激动剂领域，阿斯利康以总价18亿美元收购AmolytPharma，获得了处于临床3期的PTH1R激动剂eneboparatide，目前该疗法已经获得了FDA快速通道认定，另一家药企AscendisPharma的Yorvipath获得FDA批准上市，用于治疗成人慢性甲状旁腺功能减退。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-25/doc-incxhqmk8147031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4599","BK4539","BK4082","SEPN","BDMD","TQQQ","BK4200","BK4561","BK4139","BK4007","PSQ","QID","QLD",".IXIC","GPCR","SYRS","SQQQ","OMGA","AVTE","CAMP","BK4020","ASO","UPB","TSLP","GLYC","NQmain","MNQmain","APGE"],"gpt_icon":1},{"id":"2485228298","title":"硕迪生物盘中异动 早盘快速拉升5.22%报31.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485228298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485228298?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:48","pubTimestamp":1732290503,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时48分，硕迪生物股票出现波动，股价急速拉升5.22%。截至发稿，该股报31.67美元/股，成交量22.4414万股，换手率0.39%，振幅6.88%。机构评级方面，在所有8家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122234823abd7b2e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122234823abd7b2e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.structuretx.com","stockEarnings":[{"period":"1week","weight":-0.1072},{"period":"1month","weight":-0.147},{"period":"3month","weight":-0.3344},{"period":"6month","weight":-0.3878},{"period":"1year","weight":-0.1545},{"period":"ytd","weight":-0.3155}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"硕迪生物公司于2019年2月在开曼群岛成立，在美国和中国设有运营子公司。该公司是一家临床阶段的全球生物制药公司，旨在开发和提供新型口服疗法，以治疗各种慢性疾病，满足医疗需求。公司的差异化技术平台利用基于结构的药物发现和计算化学专业知识，使公司能够开发口服小分子疗法，用于治疗各种疾病，包括影响代谢、心血管和肺系统的疾病。","exchange":"NASDAQ","name":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","nameEN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD,GPCR,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票老虎,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票老虎国际,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD行情,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票行情,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股价,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股市,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票价格,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票交易,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票购买,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}